-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Shisi Pharmaceutical Group (02005.HK) announced that the group's bevanolol hydrochloride has been approved by the China National Drug Administration to register as an active ingredient for use in marketed formulations, and is the third domestic company to be approved.

Zhitongcaijing·11/13/2026 10:01:11
Listen to the news
Zhitong Finance App News, Shisi Pharmaceutical Group (02005.HK) announced that the group's bevanolol hydrochloride has been approved by the China National Drug Administration to register as an active ingredient for use in marketed formulations, and is the third domestic company to be approved.